Bridging the gap between oncology and primary care
Cancer Center expert featured in Cancer Therapy Advisor article
The University of Cincinnati Cancer Center's Melissa Erickson was featured in a Cancer Therapy Advisor article discussing the importance of oncology and primary care synergy to support cancer survivors.
Erickson and colleagues launched the Cancer Center's oncology primary care clinic, one of the only clinics of its kind in the country, in 2021.
“Robust survivorship care is important because cancer patients have a unique set of medical needs,” said Erickson, MD, director of cancer survivorship and supportive services at the Cancer Center and adjunct assistant professor in UC's College of Medicine. “When these needs are unmet, the quality of life of these survivors is diminished.”
Read the Cancer Therapy Advisor article.
Featured image at top: Exterior of the College of Medicine's CARE/Crawley Building. Photo/University of Cincinnati.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.